Charting the NF-κB pathway interactome map

PLoS ONE

Volumn 7, Issue 3, 2012, Pages

  Tieri, Paolo ^a,b   Termanini, Alberto ^a   Bellavista, Elena ^a   Salvioli, Stefano ^a   Capri, Miriam ^a   Franceschi, Claudio ^a  

^a UNIVERSITY OF BOLOGNA   (Italy)

^b CNR   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN ENHANCER BINDING PROTEIN;

ARTICLE; CONTROLLED STUDY; DOWN REGULATION; FEEDBACK SYSTEM; GENE CONTROL; GENE EXPRESSION REGULATION; GENETIC DATABASE; MOLECULAR DYNAMICS; PREDICTION; PROTEIN DATABASE; PROTEIN DEGRADATION; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; PROTEIN PROTEIN INTERACTION; SIGNAL TRANSDUCTION; TRANSCRIPTION REGULATION; UPREGULATION; HUMAN; METABOLISM; METHODOLOGY; MOLECULAR GENETICS; PROTEIN ANALYSIS;

HUMANS; MOLECULAR SEQUENCE ANNOTATION; NF-KAPPA B; PROTEIN INTERACTION MAPPING; SIGNAL TRANSDUCTION;

EID: 84857706271     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0032678     Document Type: Article

References (118)

1. Vodovotz Y, Csete M, Bartels J, Chang S, An G, (2008) Translational systems biology of inflammation. PLoS Comput Biol 4: e1000014.
2. De Martinis M, Franceschi C, Monti D, Ginaldi L, (2005) Inflamm-ageing and lifelong antigenic load as major determinants of ageing rate and longevity. FEBS Lett 579: 2035-2039.
3. Fagiolo U, Cossarizza A, Scala E, Fanales-Belasio E, Ortolani C, et al. (1993) Increased cytokine production in mononuclear cells of healthy elderly people. Eur J Immunol 23: 2375-2378.
4. Alberti S, Cevenini E, Ostan R, Capri M, Salvioli S, et al. (2006) Age-dependent modifications of Type 1 and Type 2 cytokines within virgin and memory CD4+ T cells in humans. Mech Ageing Dev 127: 560-566.
5. Wikby A, Nilsson BO, Forsey R, Thompson J, Strindhall J, et al. (2006) The immune risk phenotype is associated with IL-6 in the terminal decline stage: findings from the Swedish NONA immune longitudinal study of very late life functioning. Mech Ageing Dev 127: 695-704.
6. Vescovini R, Biasini C, Fagnoni FF, Telera AR, Zanlari L, et al. (2007) Massive load of functional effector CD4+ and CD8+ T cells against cytomegalovirus in very old subjects. J Immunol 179: 4283-4291.
7. Ostan R, Bucci L, Capri M, Salvioli S, Scurti M, et al. (2008) Immunosenescence and immunogenetics of human longevity. Neuroimmunomodulation 15: 224-240.
8. Franceschi C, Bonafè M, Valensin S, Olivieri F, De Luca M, et al. (2000) Inflamm-aging. An evolutionary perspective on immunosenescence. Ann N Y Acad Sci 908: 244-254.
9. Franceschi C, Capri M, Monti D, Giunta S, Olivieri F, et al. (2007) Inflammaging and anti-inflammaging: a systemic perspective on aging and longevity emerged from studies in humans. Mech Ageing Dev 128: 92-105.
10. Cevenini E, Bellavista E, Tieri P, Castellani G, Lescai F, et al. (2010) Systems Biology and Longevity: An Emerging Approach to Identify Innovative Anti-Aging Targets and Strategies. Current Pharmaceutical Design pp. 802-813.
11. Vescovini R, Biasini C, Telera AR, Basaglia M, Stella A, et al. (2010) Intense antiextracellular adaptive immune response to human cytomegalovirus in very old subjects with impaired health and cognitive and functional status. J Immunol 184: 3242-3249.
12. Pahl H, (1999) Activators and target genes of Rel/NF-kappaB transcription factors. Oncogene 18: 6853-6866.
13. Gilmore T, (2010) Rel/NF-kappaB Transcription Factors. Boston.
14. Perkins N, (2007) Integrating cell-signalling pathways with NF-kappaB and IKK function. Nat Rev Mol Cell Biol 8: 49-62.
15. Lenardo M, Baltimore D, (1989) NF-kappa B: a pleiotropic mediator of inducible and tissue-specific gene control. Cell 58: 227-229.
16. Hoffmann A, Baltimore D, (2006) Circuitry of nuclear factor kappaB signaling. Immunol Rev 210: 171-186.
17. Schmitz M, Mattioli I, Buss H, Kracht M, (2004) NF-kappaB: a multifaceted transcription factor regulated at several levels. Chembiochem 5: 1348-1358.
18. Wong E, Tergaonkar V, (2009) Roles of NF-kappaB in health and disease: mechanisms and therapeutic potential. Clin Sci (Lond) 116: 451-465.
19. Ben-Neriah Y, Karin M, (2011) Inflammation meets cancer, with NF-κB as the matchmaker. Nat Immunol 12: 715-723.
20. Editorial, (2011) Celebrating 25 years of NF-κB. Nat Immunol 12: 681.
21. Baltimore D, (2011) NF-κB is 25. Nat Immunol 12: 683-685.
22. Fraser I, Germain R, (2009) Navigating the network: signaling cross-talk in hematopoietic cells. Nat Immunol 10: 327-331.
23. Friedman A, Perrimon N, (2007) Genetic screening for signal transduction in the era of network biology. Cell 128: 225-231.
24. Boutros M, Ahringer J, (2008) The art and design of genetic screens: RNA interference. Nat Rev Genet 9: 554-566.
25. Bhattacharya SK, Gomes J, Cebulla CM, (2010) Toward failure analyses in systems biology. Wiley Interdisciplinary Reviews: Systems Biology and Medicine 9999: n/a.
26. Caron E, Ghosh S, Matsuoka Y, Ashton-Beaucage D, Therrien M, et al. (2010) A comprehensive map of the mTOR signaling network. Mol Syst Biol 6: 453.
27. Wu G, Zhu L, Dent JE, Nardini C, (2010) A comprehensive molecular interaction map for rheumatoid arthritis. PLoS One 5: e10137.
28. Bhalla U, Iyengar R, (1999) Emergent properties of networks of biological signaling pathways. Science 283: 381-387.
29. Bhalla U, (2003) Understanding complex signaling networks through models and metaphors. Prog Biophys Mol Biol 81: 45-65.
30. Ivakhno S, Armstrong J, (2007) Non-linear dimensionality reduction of signaling networks. BMC Syst Biol 1: 27.
31. Oeckinghaus A, Hayden MS, Ghosh S, (2011) Crosstalk in NF-κB signaling pathways. Nat Immunol 12: 695-708.
32. Smale ST, (2011) Hierarchies of NF-κB target-gene regulation. Nat Immunol 12: 689-694.
33. Killcoyne S, Carter G, Smith J, Boyle J, (2009) Cytoscape: a community-based framework for network modeling. Methods Mol Biol 563: 219-239.
34. Shannon P, Markiel A, Ozier O, Baliga N, Wang J, et al. (2003) Cytoscape: a software environment for integrated models of biomolecular interaction networks. Genome Res 13: 2498-2504.
35. Yeung N, Cline M, Kuchinsky A, Smoot M, Bader G, (2008) Exploring biological networks with Cytoscape software. Curr Protoc Bioinformatics Chapter 8: Unit 8.13.
36. Tieri P, de la Fuente A, Termanini A, Franceschi C, (2011) Integrating omics data for signaling pathways, interactome reconstruction, and functional analysis. Methods Mol Biol 719: 415-433.
37. Prieto C, De Las Rivas J, (2006) APID: Agile Protein Interaction DataAnalyzer. Nucleic Acids Res 34: W298-302.
38. Hernandez-Toro J, Prieto C, De las Rivas J, (2007) APID2NET: unified interactome graphic analyzer. Bioinformatics 23: 2495-2497.
39. Al-Shahrour F, Díaz-Uriarte R, Dopazo J, (2004) FatiGO: a web tool for finding significant associations of Gene Ontology terms with groups of genes. Bioinformatics 20: 578-580.
40. Al-Shahrour F, Minguez P, Vaquerizas JM, Conde L, Dopazo J, (2005) BABELOMICS: a suite of web tools for functional annotation and analysis of groups of genes in high-throughput experiments. Nucleic Acids Res 33: W460-464.
41. Medina I, Carbonell J, Pulido L, Madeira SC, Goetz S, et al. (2010) Babelomics: an integrative platform for the analysis of transcriptomics, proteomics and genomic data with advanced functional profiling. Nucleic Acids Res 38: W210-213.
42. Bauer-Mehren A, Rautschka M, Sanz F, Furlong LI, (2010) DisGeNET: a Cytoscape plugin to visualize, integrate, search and analyze gene-disease networks. Bioinformatics 26: 2924-2926.
43. Klein TE, Chang JT, Cho MK, Easton KL, Fergerson R, et al. (2001) Integrating genotype and phenotype information: an overview of the PharmGKB project. Pharmacogenetics Research Network and Knowledge Base. Pharmacogenomics J 1: 167-170.
44. Assenov Y, Ramírez F, Schelhorn SE, Lengauer T, Albrecht M, (2008) Computing topological parameters of biological networks. Bioinformatics 24: 282-284.
45. Bader GD, Hogue CW, (2003) An automated method for finding molecular complexes in large protein interaction networks. BMC Bioinformatics 4: 2.
46. Joy MP, Brock A, Ingber DE, Huang S, (2005) High-betweenness proteins in the yeast protein interaction network. J Biomed Biotechnol pp. 96-103.
47. Platzer A, Perco P, Lukas A, Mayer B, (2007) Characterization of protein-interaction networks in tumors. BMC Bioinformatics 8: 224.
48. Barkett M, Gilmore T, (1999) Control of apoptosis by Rel/NF-kappaB transcription factors. Oncogene 18: 6910-6924.
49. Bell S, Matthews J, Jaffray E, Hay R, (1996) I(kappa)B(gamma) inhibits DNA binding of NF-kappaB p50 homodimers by interacting with residues that contact DNA. Mol Cell Biol 16: 6477-6485.
50. Ben-Neriah Y, (2002) Regulatory functions of ubiquitination in the immune system. Nat Immunol 3: 20-26.
51. Campbell K, O'Shea J, Perkins N, (2006) Differential regulation of NF-kappaB activation and function by topoisomerase II inhibitors. BMC Cancer 6: 101.
52. Chen L, Greene W, (2004) Shaping the nuclear action of NF-kappaB. Nat Rev Mol Cell Biol 5: 392-401.
53. Chen Z, (2005) Ubiquitin signalling in the NF-kappaB pathway. Nat Cell Biol 7: 758-765.
54. Cohen S, Achbert-Weiner H, Ciechanover A, (2004) Dual effects of IkappaB kinase beta-mediated phosphorylation on p105 Fate: SCF(beta-TrCP)-dependent degradation and SCF(beta-TrCP)-independent processing. Mol Cell Biol 24: 475-486.
55. Dobrzanski P, Ryseck R, Bravo R, (1994) Differential interactions of Rel-NF-kappa B complexes with I kappa B alpha determine pools of constitutive and inducible NF-kappa B activity. EMBO J 13: 4608-4616.
56. Donzé O, Deng J, Curran J, Sladek R, Picard D, et al. (2004) The protein kinase PKR: a molecular clock that sequentially activates survival and death programs. EMBO J 23: 564-571.
57. Elliott P, Zollner T, Boehncke W, (2003) Proteasome inhibition: a new anti-inflammatory strategy. J Mol Med 81: 235-245.
58. Franzoso G, Bours V, Park S, Tomita-Yamaguchi M, Kelly K, et al. (1992) The candidate oncoprotein Bcl-3 is an antagonist of p50/NF-kappa B-mediated inhibition. Nature 359: 339-342.
59. Gilmore T, Gapuzan M, Kalaitzidis D, Starczynowski D, (2002) Rel/NF-kappa B/I kappa B signal transduction in the generation and treatment of human cancer. Cancer Lett 181: 1-9.
60. Häcker H, Karin M, (2006) Regulation and function of IKK and IKK-related kinases. Sci STKE 2006: re13.
61. Hayden M, Ghosh S, (2004) Signaling to NF-kappaB. Genes Dev 18: 2195-2224.
62. Hayden M, West A, Ghosh S, (2006) SnapShot: NF-kappaB signaling pathways. Cell 127: 1286-1287.
63. Hinz M, Löser P, Mathas S, Krappmann D, Dörken B, et al. (2001) Constitutive NF-kappaB maintains high expression of a characteristic gene network, including CD40, CD86, and a set of antiapoptotic genes in Hodgkin/Reed-Sternberg cells. Blood 97: 2798-2807.
64. Ishinaga H, Jono H, Lim J, Kweon S, Xu H, et al. (2007) TGF-beta induces p65 acetylation to enhance bacteria-induced NF-kappaB activation. EMBO J 26: 1150-1162.
65. Krappmann D, Wegener E, Sunami Y, Esen M, Thiel A, et al. (2004) The IkappaB kinase complex and NF-kappaB act as master regulators of lipopolysaccharide-induced gene expression and control subordinate activation of AP-1. Mol Cell Biol 24: 6488-6500.
66. Malek S, Chen Y, Huxford T, Ghosh G, (2001) IkappaBbeta, but not IkappaBalpha, functions as a classical cytoplasmic inhibitor of NF-kappaB dimers by masking both NF-kappaB nuclear localization sequences in resting cells. J Biol Chem 276: 45225-45235.
67. Malek S, Huang D, Huxford T, Ghosh S, Ghosh G, (2003) X-ray crystal structure of an IkappaBbeta x NF-kappaB p65 homodimer complex. J Biol Chem 278: 23094-23100.
68. Moorthy A, Savinova O, Ho J, Wang V, Vu D, et al. (2006) The 20S proteasome processes NF-kappaB1 p105 into p50 in a translation-independent manner. EMBO J 25: 1945-1956.
69. Pasparakis M, Luedde T, Schmidt-Supprian M, (2006) Dissection of the NF-kappaB signalling cascade in transgenic and knockout mice. Cell Death Differ 13: 861-872.
70. Pham L, Tamayo A, Yoshimura L, Lin-Lee Y, Ford R, (2005) Constitutive NF-kappaB and NFAT activation in aggressive B-cell lymphomas synergistically activates the CD154 gene and maintains lymphoma cell survival. Blood 106: 3940-3947.
71. Rodriguez M, Thompson J, Hay R, Dargemont C, (1999) Nuclear retention of IkappaBalpha protects it from signal-induced degradation and inhibits nuclear factor kappaB transcriptional activation. J Biol Chem 274: 9108-9115.
72. Saccani S, Pantano S, Natoli G, (2003) Modulation of NF-kappaB activity by exchange of dimers. Mol Cell 11: 1563-1574.
73. Salminen A, Huuskonen J, Ojala J, Kauppinen A, Kaarniranta K, et al. (2008) Activation of innate immunity system during aging: NF-kB signaling is the molecular culprit of inflamm-aging. Ageing Res Rev 7: 83-105.
74. Schmitz M, Baeuerle P, (1991) The p65 subunit is responsible for the strong transcription activating potential of NF-kappa B. EMBO J 10: 3805-3817.
75. Taylor I, Wrana J, (2008) SnapShot: The TGFbeta pathway interactome. Cell 133: 378.e371.
76. Thompson J, Phillips R, Erdjument-Bromage H, Tempst P, Ghosh S, (1995) I kappa B-beta regulates the persistent response in a biphasic activation of NF-kappa B. Cell 80: 573-582.
77. Ward K, Zhang K, Somasiri A, Roskelley C, Schrader J, (2004) Expression of activated M-Ras in a murine mammary epithelial cell line induces epithelial-mesenchymal transition and tumorigenesis. Oncogene 23: 1187-1196.
78. Wegener E, Oeckinghaus A, Papadopoulou N, Lavitas L, Schmidt-Supprian M, et al. (2006) Essential role for IkappaB kinase beta in remodeling Carma1-Bcl10-Malt1 complexes upon T cell activation. Mol Cell 23: 13-23.
79. Weil R, Israël A, (2006) Deciphering the pathway from the TCR to NF-kappaB. Cell Death Differ 13: 826-833.
80. Wertz I, O'Rourke K, Zhou H, Eby M, Aravind L, et al. (2004) De-ubiquitination and ubiquitin ligase domains of A20 downregulate NF-kappaB signalling. Nature 430: 694-699.
81. Whiteside S, Epinat J, Rice N, Israël A, (1997) I kappa B epsilon, a novel member of the I kappa B family, controls RelA and cRel NF-kappa B activity. EMBO J 16: 1413-1426.
82. Wulczyn F, Naumann M, Scheidereit C, (1992) Candidate proto-oncogene bcl-3 encodes a subunit-specific inhibitor of transcription factor NF-kappa B. Nature 358: 597-599.
83. Zhao F, Xuan Z, Liu L, Zhang M, (2005) TRED: a Transcriptional Regulatory Element Database and a platform for in silico gene regulation studies. Nucleic Acids Res 33: D103-107.
84. Jiang C, Xuan Z, Zhao F, Zhang M, (2007) TRED: a transcriptional regulatory element database, new entries and other development. Nucleic Acids Res 35: D137-140.
85. Alibés A, Yankilevich P, Cañada A, Díaz-Uriarte R, (2007) IDconverter and IDClight: conversion and annotation of gene and protein IDs. BMC Bioinformatics 8: 9.
86. Peters RT, Liao SM, Maniatis T, (2000) IKKepsilon is part of a novel PMA-inducible IkappaB kinase complex. Mol Cell 5: 513-522.
87. Malinin NL, Boldin MP, Kovalenko AV, Wallach D, (1997) MAP3K-related kinase involved in NF-kappaB induction by TNF, CD95 and IL-1. Nature 385: 540-544.
88. Bista P, Zeng W, Ryan S, Bailly V, Browning JL, et al. (2010) TRAF3 controls activation of the canonical and alternative NFkappaB by the lymphotoxin beta receptor. J Biol Chem 285: 12971-12978.
89. Nourbakhsh M, Hauser H, (1999) Constitutive silencing of IFN-beta promoter is mediated by NRF (NF-kappaB-repressing factor), a nuclear inhibitor of NF-kappaB. EMBO J 18: 6415-6425.
90. Wu H, Arron JR, (2003) TRAF6, a molecular bridge spanning adaptive immunity, innate immunity and osteoimmunology. Bioessays 25: 1096-1105.
91. Hedayat M, Netea MG, Rezaei N, (2011) Targeting of Toll-like receptors: a decade of progress in combating infectious diseases. Lancet Infect Dis 11: 702-712.
92. Hehlgans T, Pfeffer K, (2005) The intriguing biology of the tumour necrosis factor/tumour necrosis factor receptor superfamily: players, rules and the games. Immunology 115: 1-20.
93. Ruland J, (2011) Return to homeostasis: downregulation of NF-κB responses. Nat Immunol 12: 709-714.
94. Sato S, Sanjo H, Takeda K, Ninomiya-Tsuji J, Yamamoto M, et al. (2005) Essential function for the kinase TAK1 in innate and adaptive immune responses. Nat Immunol 6: 1087-1095.
95. Csete M, Doyle J, (2004) Bow ties, metabolism and disease. Trends in Biotechnology 22: 446-450.
96. Yang SK, Wang YC, Chao CC, Chuang YJ, Lan CY, et al. (2010) Dynamic cross-talk analysis among TNF-R, TLR-4 and IL-1R signalings in TNFalpha-induced inflammatory responses. BMC Med Genomics 3: 19.
97. Wang YC, Chen BS, (2010) Integrated cellular network of transcription regulations and protein-protein interactions. BMC Syst Biol 4: 20.
98. Ottaviani E, (2011) Evolution of immune-neuroendocrine integration from an ecological immunology perspective. Cell Tissue Res 344: 213-215.
99. Ottaviani E, Malagoli D, Capri M, Franceschi C, (2008) Ecoimmunology: is there any room for the neuroendocrine system? Bioessays 30: 868-874.
100. Kitano H, Oda K, (2006) Robustness trade-offs and host-microbial symbiosis in the immune system. Mol Syst Biol 2: 2006.0022.
101. Tieri P, Grignolio A, Zaikin A, Mishto M, Remondini D, et al. (2010) Network, degeneracy and bow tie integrating paradigms and architectures to grasp the complexity of the immune system. Theor Biol Med Model 7: 32.
102. Vitali S, Glattfelder JB, Battiston S, (2011) The network of global corporate control. PLoS One 6: e25995.
103. Wu H, Lozano G, (1994) NF-kappa B activation of p53. A potential mechanism for suppressing cell growth in response to stress. J Biol Chem 269: 20067-20074.
104. Pei XH, Nakanishi Y, Takayama K, Bai F, Hara N, (1999) Benzo[a]pyrene activates the human p53 gene through induction of nuclear factor kappaB activity. J Biol Chem 274: 35240-35246.
105. Qin C, Nguyen T, Stewart J, Samudio I, Burghardt R, et al. (2002) Estrogen up-regulation of p53 gene expression in MCF-7 breast cancer cells is mediated by calmodulin kinase IV-dependent activation of a nuclear factor kappaB/CCAAT-binding transcription factor-1 complex. Mol Endocrinol 16: 1793-1809.
106. Ikeda A, Sun X, Li Y, Zhang Y, Eckner R, et al. (2000) p300/CBP-dependent and-independent transcriptional interference between NF-kappaB RelA and p53. Biochem Biophys Res Commun 272: 375-379.
107. Jeong SJ, Radonovich M, Brady JN, Pise-Masison CA, (2004) HTLV-I Tax induces a novel interaction between p65/RelA and p53 that results in inhibition of p53 transcriptional activity. Blood 104: 1490-1497.
108. Ravi R, Mookerjee B, van Hensbergen Y, Bedi GC, Giordano A, et al. (1998) p53-mediated repression of nuclear factor-kappaB RelA via the transcriptional integrator p300. Cancer Res 58: 4531-4536.
109. Schneider G, Henrich A, Greiner G, Wolf V, Lovas A, et al. (2010) Cross talk between stimulated NF-kappaB and the tumor suppressor p53. Oncogene 29: 2795-2806.
110. Vasudevan KM, Gurumurthy S, Rangnekar VM, (2004) Suppression of PTEN expression by NF-kappa B prevents apoptosis. Mol Cell Biol 24: 1007-1021.
111. Ying H, Elpek KG, Vinjamoori A, Zimmerman SM, Chu GC, et al. (2011) Pten is a major tumor suppressor in pancreatic ductal adenocarcinoma and regulates an NF-κB-cytokine network. Cancer Discov 1: 158-169.
112. Vereecke L, Beyaert R, van Loo G, (2009) The ubiquitin-editing enzyme A20 (TNFAIP3) is a central regulator of immunopathology. Trends Immunol 30: 383-391.
113. Renner F, Schmitz ML, (2009) Autoregulatory feedback loops terminating the NF-kappaB response. Trends Biochem Sci 34: 128-135.
114. Simkó GI, Gyurkó D, Veres DV, Nánási T, Csermely P, (2009) Network strategies to understand the aging process and help age-related drug design. Genome Med 1: 90.
115. Chen Y, Wang H, Yoon SO, Xu X, Hottiger MO, et al. (2011) HDAC-mediated deacetylation of NF-κB is critical for Schwann cell myelination. Nat Neurosci 14: 437-441.
116. Bhattacharya SK, (2010) Towards a matrix mechanics framework for dynamic protein network. Syst Synth Biol 4: 139-144.
117. Cheong R, Hoffmann A, Levchenko A, (2008) Understanding NF-kappaB signaling via mathematical modeling. Mol Syst Biol 4: 192.
118. Lecca P, Nguyen TP, Priami C, Quaglia P, (2011) Network inference from time-dependent Omics data. Methods Mol Biol 719: 435-455.